Cancer-Fighting cell therapy now aimed at curing stubborn kidney disease
NCT ID NCT07266181
Summary
This early-stage study is testing whether a therapy called CAR-T, which is used for some cancers, can help people with a severe form of kidney disease that hasn't responded to other treatments. Doctors will collect immune cells from 5 patients, modify them to target the disease, and infuse them back to see if it's safe and can reduce kidney damage. The main goal is to check for serious side effects, while also looking for signs that the treatment helps control the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REFRACTORY MEMBRANOUS NEPHROPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Nephrology, Xijing Hospital
RECRUITINGXi'an, China, 710012, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.